Top

Published in:

01-09-2015 | Review

Acute disseminated encephalomyelitis: current controversies in diagnosis and outcome

Authors: Diederik L. H. Koelman, Farrah J. Mateen

Published in: Journal of Neurology | Issue 9/2015

Abstract

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory, demyelinating disorder of the CNS. Only in the past 15 years have larger groups of patients from several geographical areas been reported for comparisons across studies. In spite of the increased recognition of ADEM, the diagnosis of ADEM remains clinical, aided by neuroimaging confirmation, because of the lack of a biological marker. The diagnosis may be difficult, given that several diseases may present similar to ADEM. The controversial existence of multiphasic forms necessitates a continuous evaluation of the diagnosis by tracking subsequent events. Despite proposed consensus criteria, the diagnostic criteria employed to characterize ADEM range widely among the largest reported cohorts to date. This review comprehensively evaluates the current knowledge and controversies that surround ADEM, with special consideration of the distinction between ADEM and other demyelinating diseases such as multiple sclerosis. In addition, we present implications of the current knowledge of ADEM for both research and clinical practice.

Available only for authorised users

Clifton F (1724) Dissertatio Medica Inauguralis; de Distinctis et Confluentibus Variolis. section IX

Brinar VV (2004) Non-MS recurrent demyelinating diseases. Clin Neurol Neurosurg 106:197–210CrossRefPubMed

Anton G, Wohlwill F (1912) Multiple nicht eitrige enzephalomyelitis und multiple sklerose. Z Gesamte Neurol Psy 12:31–98CrossRef

Koprowski H (1962) The role of hyperergy in measles encephalitis. Am J Dis Child 103:273–278PubMed

Pohl D, Hennemuth I, von Kries R, Hanefeld F (2007) Paediatric multiple sclerosis and acute disseminated encephalomyelitis in Germany: results of a nationwide survey. Eur J Pediatr 166:405–412CrossRefPubMed

Leake JAD, Albani S, Kao AS et al (2004) Acute disseminated encephalomyelitis in childhood: epidemiologic, clinical and laboratory features. Pediatr Infect Dis J 23:756–764CrossRefPubMed

Banwell B, Kennedy J, Sadovnick D et al (2009) Incidence of acquired demyelination of the CNS in Canadian children. Neurology 72:232–239CrossRefPubMed

Torisu H, Kira R, Ishizaki Y et al (2010) Clinical study of childhood acute disseminated encephalomyelitis, multiple sclerosis, and acute transverse myelitis in Fukuoka Prefecture, Japan. Brain Dev 32:454–462CrossRefPubMed

Hung K-L, Liao H-T, Tsai M-L (2001) The spectrum of postinfectious encephalomyelitis. Brain Dev 23:42–45CrossRefPubMed

10.

Tenembaum S, Chamoles N, Fejerman N (2002) Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients. Neurology 59:1224–1231CrossRefPubMed

11.

Idrissova ZR, Boldyreva MN, Dekonenko EP et al (2003) Acute disseminated encephalomyelitis in children: clinical features and HLA-DR linkage. Eur J Neurol 10:537–546CrossRefPubMed

12.

Singhi PD, Ray M, Singhi S, Khandelwal NK (2006) Acute disseminated encephalomyelitis in North Indian children: clinical profile and follow-up. J Child Neurol 21:851–857CrossRefPubMed

13.

Mikaeloff Y, Caridade G, Husson B et al (2007) Acute disseminated encephalomyelitis cohort study: prognostic factors for relapse. Eur J Paediatr Neurol 11:90–95CrossRefPubMed

14.

De Seze J, Debouverie M, Zephir H (2007) Acute fulminant demyelinating disease. Arch Neurol 64:1426–1432CrossRefPubMed

15.

Panicker JN, Nagaraja D, Kovoor JME, Subbakrishna DK (2010) Descriptive study of acute disseminated encephalomyelitis and evaluation of functional outcome predictors. J Postgrad Med 56:12–16CrossRefPubMed

16.

Ketelslegers IA, Visser IER, Neuteboom RF et al (2011) Disease course and outcome of acute disseminated encephalomyelitis is more severe in adults than in children. Mult Scler 17:441–448CrossRefPubMed

17.

Marchioni E, Ravaglia S, Montomoli C (2013) Postinfectious neurologic syndromes: a prospective cohort study. Neurology 80:882–889CrossRefPubMed

18.

Bonaccorsi A, Garattine S, Jori A (1964) Neurological complications of smallpox vaccination. Br Med J 2:1345–1347CrossRefPubMed

19.

Behan PO (2009) Acute disseminated encephalomyelitis: postinfectious, postimmunization and variant forms. Expert Rev Neurother 9:1321–1329CrossRefPubMed

20.

Langer-Gould A, Zhang J, Chung J et al (2011) Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children. Neurology 77:1143–1148PubMedCentralCrossRefPubMed

21.

Dale RC, de Sousa C, Chong WK et al (2000) Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain 123:2407–2422CrossRefPubMed

22.

Murthy SNK, Faden HS, Cohen ME, Bakshi R (2002) Acute Disseminated Encephalomyelitis in Children. Pediatrics 110:e21CrossRefPubMed

23.

Erol I, Ozkale Y, Alkan O, Alehan F (2013) Acute disseminated encephalomyelitis in children and adolescents: a single center experience. Pediatr Neurol 49:266–273CrossRefPubMed

24.

Tenembaum SN (2013) Acute disseminated encephalomyelitis. Handb Clin Neurol 112:1253–1262CrossRefPubMed

25.

Lucas J (1790) An account of uncommon symptoms succeeding the measles with additional remarks on the infection of measles and smallpox. London Med J 11:325–331

26.

Krupp LB, Tardieu M, Amato MP et al (2013) International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler 19:1261–1267CrossRefPubMed

27.

Caldemeyer KS, Harris TM, Smith RR, Edwards MK (1991) Gadolinium enhancement in acute disseminated encephalomyelitis. J Comput Assist Tomogr 15:673–675CrossRefPubMed

28.

Baum PA, Barkovich AJ, Koch TK, Berg B (1992) Deep gray matter involvement in children with acute disseminated encephalomyelitis. Am J Neuroradiol 15:1275–1283

29.

Lakhan SE (2012) Section editor teaching neuro images: MRI time lag with acute disseminated encephalomyelitis. Neurology e138–e139

30.

Khurana DS, Melvin JJ, Kothare SV et al (2005) Acute disseminated encephalomyelitis in children: discordant neurologic and neuroimaging abnormalities and response to plasmapheresis. Pediatrics 116:431–436CrossRefPubMed

31.

Chitnis T (2013) Pediatric demyelinating diseases. Continuum 19:1023–1045

32.

Sejvar JJ, Kohl KS, Bilynsky R et al (2007) Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 25:5771–5792CrossRefPubMed

33.

Pohl D, Tenembaum SN (2012) Treatment of acute disseminated encephalomyelitis. Curr Treat Options Neurol 14:264–275CrossRefPubMed

34.

Keegan M, Pineda AA, McClelland RL et al (2002) Plasma exchange for severe attacks of CNS demyelination : predictors of response. Neurology 58:143–146CrossRefPubMed

35.

Marchioni E, Ravaglia S, Piccolo G et al (2005) Postinfectious inflammatory disorders: subgroups based on prospective follow-up. Neurology 65:1057–1065CrossRefPubMed

36.

Absoud M, Parslow RC, Wassmer E et al (2011) Severe acute disseminated encephalomyelitis: a paediatric intensive care population-based study. Mult Scler 17:1258–1261CrossRefPubMed

37.

Polman CH, Reingold SC, Banwell B et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69:292–302PubMedCentralCrossRefPubMed

38.

Banwell B, Bar-Or A, Arnold DL et al (2011) Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study. Lancet Neurol 10:436–445CrossRefPubMed

39.

Banwell B, Krupp L, Kennedy J et al (2007) Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study. Lancet Neurol 6:773–781CrossRefPubMed

40.

Banwell BL (2004) Pediatric multiple sclerosis. Curr Neurol Neurosci Rep 4:245–252CrossRefPubMed

41.

Marrie RA, Wolfson C, Sturkenboom MCJM et al (2000) Multiple sclerosis and antecedent infections: a case-control study. Neurology 54:2307–2310CrossRefPubMed

42.

Schwarz S, Mohr A, Knauth M et al (2001) Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients. Neurology 56:1313–1318CrossRefPubMed

43.

Neuteboom RF, Boon M, Catsman Berrevoets CE et al (2008) Prognostic factors after a first attack of inflammatory CNS demyelination in children. Neurology 71:967–973CrossRefPubMed

44.

Kesselring J, Miller DH, Robb SA et al (1990) Acute disseminated encephalomyelitis; mri findings and the distiction from multiple sclerosis. Brain J Neurol 113:291–302CrossRef

45.

Absoud M, Lim MJ, Appleton R et al (2014) Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features. J Neurol Neurosurg Psychiatry. doi:10.1136/jnnp-2014-308550

46.

Okumura A, Nakazawa M, Igarashi A et al (2014) Anti-aquaporin 4 antibody-positive acute disseminated encephalomyelitis. Brain Dev 37:339–343CrossRefPubMed

47.

Cheng C, Jiang Y, Chen X et al (2013) Clinical, radiographic characteristics and immunomodulating changes in neuromyelitis optica with extensive brain lesions. BMC Neurol 13:72PubMedCentralCrossRefPubMed

48.

Saiki S, Ueno Y, Moritani T et al (2009) Extensive hemispheric lesions with radiological evidence of blood-brain barrier integrity in a patient with neuromyelitis optica. J Neurol Sci 284:217–219CrossRefPubMed

49.

Eichel R, Meiner Z, Abramsky O, Gotkine M (2008) Acute disseminating encephalomyelitis in neuromyelitis optica: closing the floodgates. Arch Neurol 65:267–271CrossRefPubMed

50.

Beyer AM, Wandinger KP, Siebert E et al (2007) Neuromyelitis optica in a patient with an early onset demyelinating episode: clinical and autoantibody findings. Clin Neurol Neurosurg 109:926–930CrossRefPubMed

51.

Alper G, Heyman R, Wang L (2009) Multiple sclerosis and acute disseminated encephalomyelitis diagnosed in children after long-term follow-up: comparison of presenting features. Dev Med Child Neurol 51:480–486PubMedCentralCrossRefPubMed

52.

Neuteboom RF, Ketelslegers IA, Boon M et al (2010) Barkhof magnetic resonance imaging criteria predict early relapse in pediatric multiple sclerosis. Pediatr Neurol 42:53–55CrossRefPubMed

53.

Verhey LH, Branson HM, Shroff MM et al (2011) MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study. Lancet Neurol 10:1065–1073CrossRefPubMed

54.

Callen DJA, Shroff MM, Branson HM et al (2009) Role of MRI in the differentiation of ADEM from MS in children. Neurology 72:968–973CrossRefPubMed

55.

Mikaeloff Y, Adamsbaum C, Husson B et al (2004) MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood. Brain 127:1942–1947CrossRefPubMed

56.

Zhang L, Wu A, Zhang B et al (2014) Comparison of deep gray matter lesions on magnetic resonance imaging among adults with acute disseminated encephalomyelitis, multiple sclerosis, and neuromyelitis optica. Mult Scler 20:418–423CrossRefPubMed

57.

Lu Z, Zhang B, Qiu W et al (2011) Comparative brain stem lesions on MRI of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis. PLoS One 6:e22766PubMedCentralCrossRefPubMed

58.

Vishwas MS, Healy BC, Pienaar R et al (2013) Diffusion tensor analysis of pediatric multiple sclerosis and clinically isolated syndromes. Am J Neuroradiol 34:417–423CrossRefPubMed

59.

Absoud M, Lim MJ, Chong WK et al (2013) Paediatric acquired demyelinating syndromes: incidence, clinical and magnetic resonance imaging features. Mult Scler 19:76–86PubMedCentralCrossRefPubMed

60.

Pohl D, Rostasy K, Reiber H, Hanefeld F (2004) CSF characteristics in early-onset. Neurology 1966–1967

61.

Young NP, Weinshenker BG, Parisi JE et al (2010) Perivenous demyelination: association with clinically defined acute disseminated encephalomyelitis and comparison with pathologically confirmed multiple sclerosis. Brain a J Neurol 133:333–348CrossRef

62.

Tsai M-L, Hung K-L (1996) Multiphasic disseminated encephalomyelitis mimicking multiple sclerosis. Brain Dev 18:412–414CrossRefPubMed

63.

Mikaeloff Y, Suissa S, Vallée L et al (2004) First epidose of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability. J Pediatr 144:246–252CrossRefPubMed

64.

Fridinger SE, Alper G (2013) Defining Encephalopathy in Acute Disseminated Encephalomyelitis. J Child Neurol 29:751–755CrossRefPubMed

65.

Waldman AT, Gorman MP, Rensel MR et al (2011) Management of pediatric central nervous system demyelinating disorders: consensus of United States neurologists. J Child Neurol 26:675–682PubMedCentralCrossRefPubMed

66.

Alper G, Sreedher G, Zuccoli G (2013) Isolated brain stem lesion in children: is it acute disseminated encephalomyelitis or not? Am J Neuroradiol 34:217–220CrossRefPubMed

67.

Dale RC, Pillai SC (2007) Early relapse risk after a first CNS inflammatory demyelination episode: examining international consensus definitions. Dev Med Child Neurol 887–893

68.

Peche SS, Alshekhlee A, Kelly J et al (2013) A long-term follow-up study using IPMSSG criteria in children with CNS demyelination. Pediatr Neurol 49:329–334CrossRefPubMed

69.

Visudtibhan A, Tuntiyathorn L, Vaewpanich J et al (2010) Acute disseminated encephalomyelitis: a 10-year cohort study in Thai children. Eur J Paediatr Neurol 14:513–518CrossRefPubMed

70.

Ketelslegers IA, Neuteboom RF, Boon M et al (2010) A comparison of MRI criteria for diagnosing pediatric ADEM and MS. Neurology 74:1412–1415CrossRefPubMed

71.

O’Connor KC, McLaughlin KA, De Jager PL et al (2007) Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Nat Med 13:211–217PubMedCentralCrossRefPubMed

72.

Van Haren K, Tomooka BH, Kidd BA et al (2013) Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing-remitting multiple sclerosis. Mult Scler 19:1726–1733PubMedCentralCrossRefPubMed

73.

Di Pauli F, Mader S, Rostasy K et al (2011) Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases. Clin Immunol 138:247–254CrossRefPubMed

74.

Brilot F, Dale RC, Selter RC et al (2009) Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease. Ann Neurol 66:833–842CrossRefPubMed

75.

Baumann M, Sahin K, Lechner C et al (2014) Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein. J Neurol Neurosurg Psychiatry. doi:10.1136/jnnp-2014-308346

76.

Probstel A, Downmair K, Bittner R, et al. (2011) Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis

77.

Lalive PH, Häusler MG, Maurey H et al (2011) Highly reactive anti-myelin oligodendrocyte glycoprotein antibodies differentiate demyelinating diseases from viral encephalitis in children. Mult Scler 17:297–302CrossRefPubMed

78.

Mader S, Gredler V, Schanda K et al (2011) Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J Neuroinflamm 8:184CrossRef

79.

Huppke P, Rostasy K, Karenfort M et al (2013) Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients. Mult Scler 19:941–946CrossRefPubMed

80.

Hacohen Y, Absoud M, Woodhall M et al (2014) Autoantibody biomarkers in childhood-acquired demyelinating syndromes: results from a national surveillance cohort. J Neurol Neurosurg Psychiatry 85:456–461CrossRefPubMed

81.

Lekoubou A, Viaccoz A, Didelot A et al (2012) Anti-N-methyl-d-aspartate receptor encephalitis with acute disseminated encephalomyelitis-like MRI features. Eur J Neurol 19:16–17CrossRef

82.

Titulaer MJ, Höftberger R, Iizuka T et al (2014) Overlapping demyelinating syndromes and anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol 75:411–428PubMedCentralCrossRefPubMed

Title: Acute disseminated encephalomyelitis: current controversies in diagnosis and outcome
Authors: Diederik L. H. Koelman
Farrah J. Mateen
Publication date: 01-09-2015
Publisher: Springer Berlin Heidelberg
Published in: Journal of Neurology / Issue 9/2015
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-015-7694-7

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Acute disseminated encephalomyelitis: current controversies in diagnosis and outcome

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 9/2015

Polyneuritis cranialis: oculopharyngeal subtype of Guillain-Barré syndrome

Recent imaging advances in neurology

Sample size calculations for clinical trials targeting tauopathies: a new potential disease target

An inflammatory myopathy unmasks a case of leprosy in an Italian patient

Long-term outcome of vertigo and dizziness associated disorders following treatment in specialized tertiary care: the Dizziness and Vertigo Registry (DiVeR) Study

And Pavlov still rings a bell: summarising the evidence for the use of a bell in Pavlov’s iconic experiments on classical conditioning